Use PARP-Inhibitors Early in Therapy for Metastatic Breast Cancer | Improve Response & Delay Toxic Therapy Use

Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco shares Use PARP-Inhibitors Early in Therapy for Metastatic Breast Cancer | Improve Response & Delay Toxic Therapy Use at Annual Meeting 2018